about
Dendrimer-protein interactions studied by tryptophan room temperature phosphorescence.Biophysical studies of interaction between hydrolysable tannins isolated from Oenothera gigas and Geranium sanguineum with human serum albumin.Nanoparticle corona for proteins: mechanisms of interaction between dendrimers and proteins.Influence of core and maltose surface modification of PEIs on their interaction with plasma proteins-Human serum albumin and lysozyme.Effect of low-power red light laser irradiation on the viability of human skin fibroblast.Combined effect of low-power laser irradiation and anthraquinone anticancer drug aclarubicin on survival of immortalized cells: Comparison with mitoxantrone.Characterization of complexes formed by polypropylene imine dendrimers and anti-HIV oligonucleotides.Highly organized self-assembled dendriplexes based on poly(propylene imine) glycodendrimer and anti-HIV oligodeoxynucleotides.Influence of MLS laser radiation on erythrocyte membrane fluidity and secondary structure of human serum albuminThe effect of near-infrared MLS laser radiation on cell membrane structure and radical generation.Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier.Dendrimers in gene transfection.Influence of dendrimers on red blood cells.Dendrimers in photodynamic therapy.Nanomaterials in stroke treatment: perspectives.Poly(amidoamine) dendrimer complexes as a platform for gene delivery.Interaction of cationic carbosilane dendrimers and their complexes with siRNA with erythrocytes and red blood cell ghosts.How to study dendrimers and dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo.Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report.Water-soluble carbosilane dendrimers protect phosphorothioate oligonucleotides from binding to serum proteins.Phosphorus-containing nanoparticles: biomedical patents review.Interactions between PAMAM dendrimers and bovine serum albumin.Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study.Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays.PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells.Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway.Carbosilane dendrimers inhibit α-synuclein fibrillation and prevent cells from rotenone-induced damage.Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.Doxycycline-regulated GDNF expression promotes axonal regeneration and functional recovery in transected peripheral nerve.Promising low-toxicity of viologen-phosphorus dendrimers against embryonic mouse hippocampal cells.Mechanism of cationic phosphorus dendrimer toxicity against murine neural cell lines.Viologen-phosphorus dendrimers exhibit minor toxicity against a murine neuroblastoma cell line.Modified PAMAM dendrimer with 4-carbomethoxypyrrolidone surface groups reveals negligible toxicity against three rodent cell-lines.Aligned collagen-GAG matrix as a 3D substrate for Schwann cell migration and dendrimer-based gene delivery.Cytotoxicity and genotoxicity of cationic phosphorus-containing dendrimers.Molecular properties of lysine dendrimers and their interactions with Aβ-peptides and neuronal cells.Surface modification of PAMAM dendrimer improves its biocompatibility.Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity.Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.Biomolecular Interactions of Tannin Isolated from Oenothera gigas with Liposomes.
P50
Q30357546-C457D009-F5A0-4B35-8B09-329F8B5E165BQ30369235-73CEEB87-78DC-4606-A176-A853F42BE1BBQ30377256-43E978F0-C5D3-4533-9B11-E7354B509973Q30397174-ab63d9c8-4969-9478-5fc6-aea4a21cce6bQ31961513-DB420868-D26A-4399-8A5F-FAD516D99DC0Q33251240-B0E1083E-5345-4F3B-A3F0-C906DCCA7F84Q33781847-18F15DC6-BC65-49DB-9115-6D2626070E8BQ34352672-ed2f8cec-43f1-c8a9-9642-3ce639e781bdQ35072276-9DAF7283-1B59-4DB6-8E92-9BB3B14EFFFDQ35144293-7A54C2AD-793B-485A-8DA7-3B44ED2FE9AEQ37378143-93DCDB63-250E-4CD3-9780-726AACA94247Q37633599-A6685B32-40F4-4E75-A8AA-04A6BF6B46FEQ37956522-6497EAD0-51DE-45CA-B2B2-400C10923604Q38042143-99E558F7-6180-45DE-B0DA-B27863D2EC74Q38110207-F8D44B7B-023B-49CD-987A-9EDFF5302C7DQ38156233-C4C669C1-54FA-476A-8980-3C7F89FA9EF3Q38169458-DEF46B5E-3645-4342-9AD7-8BECBC253ADAQ38194354-74AF27EF-0965-4B5E-B85F-F90BAA2C51FAQ38271652-19057C26-4D42-4977-B85C-4DAA19F45E56Q38301086-98383D5E-9B34-4882-87BA-8A8F01AEB558Q38341958-3DFB5028-E854-4295-963B-985385B31FCAQ38354426-A5ED5AC7-7F79-426F-BF94-D630C3F7552AQ38649711-2967f731-41da-6ac6-e6e5-05c298411280Q38761549-adacbcab-4e1a-0c8d-db29-111418c9e608Q38780337-02b90494-46ea-5362-9778-2da7975d7d3eQ38785427-5d35d294-4a11-da6a-6496-c0d114a36c89Q38904211-906E6665-7C7B-4B2D-A4AE-D9D030CB50BAQ39041260-10afe1e7-4c33-d161-060a-a5cef97c2cc4Q39076599-651C8448-D894-4B3D-85BA-D4B37BB60C7AQ39089271-A53612D2-6626-4D40-B63B-71714CE11705Q39118132-A2C5530F-805A-46ED-9393-09DB0D3EBCD1Q39119209-A9C7A465-4687-4531-A3AF-9FE52D5430E8Q39189845-C286E114-C6ED-4251-AE1A-62926C79386AQ39197700-7F2B3958-0137-4C1C-B2A9-0F1273D4FDD6Q39254538-C1CE731B-7A3F-477F-B416-09E770D3EEF8Q39266594-3D2047F4-C5BC-4264-B5FE-22C3135707E4Q39357061-A2F0E337-402F-4371-B582-1F3A6959E3BFQ39796837-99B86C7A-C6DB-4E91-9EE6-6A35B11A0B80Q39947075-5539C138-BB18-49AE-B82C-39DB79A13A8AQ40258741-8244195A-FF09-4977-80C4-E7B76C6C8370
P50
description
Pools onderzoekster
@nl
hulumtuese
@sq
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Maria Bryszewska
@ast
Maria Bryszewska
@ca
Maria Bryszewska
@cs
Maria Bryszewska
@de
Maria Bryszewska
@en
Maria Bryszewska
@es
Maria Bryszewska
@gl
Maria Bryszewska
@hr
Maria Bryszewska
@hsb
Maria Bryszewska
@it
type
label
Maria Bryszewska
@ast
Maria Bryszewska
@ca
Maria Bryszewska
@cs
Maria Bryszewska
@de
Maria Bryszewska
@en
Maria Bryszewska
@es
Maria Bryszewska
@gl
Maria Bryszewska
@hr
Maria Bryszewska
@hsb
Maria Bryszewska
@it
altLabel
Maria Jolanta Bryszewska
@pl
prefLabel
Maria Bryszewska
@ast
Maria Bryszewska
@ca
Maria Bryszewska
@cs
Maria Bryszewska
@de
Maria Bryszewska
@en
Maria Bryszewska
@es
Maria Bryszewska
@gl
Maria Bryszewska
@hr
Maria Bryszewska
@hsb
Maria Bryszewska
@it
P214
P244
P106
P1153
7007024546
P1412
P1559
Maria Bryszewska
@pl
P21
P213
0000 0001 1252 9663
P214
P244
n2007181273
P27
P31
P3124
P496
0000-0003-4676-3743
P7859
lccn-n2007181273